Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Deutsche Bank AG trimmed its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 14.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,965,592 shares of the biopharmaceutical company’s stock after selling 1,167,311 shares during the period. Deutsche […]
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) insider Merdad Parsey sold 2,000 shares of the company’s stock in a transaction on Wednesday, February 28th. The shares were sold at an average price of $73.18, for a total value of $146,360.00. Following the completion of the transaction, the insider now directly owns 100,936 shares in […]
Mutual Advisors LLC raised its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 4.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 27,204 shares of the biopharmaceutical company’s stock after buying an additional 1,064 shares during the period. Mutual Advisors LLC’s holdings […]
Truist Financial cut shares of Gilead Sciences (NASDAQ:GILD – Free Report) from a buy rating to a hold rating in a research report sent to investors on Thursday, Marketbeat.com reports. They currently have $82.00 price target on the biopharmaceutical company’s stock, down from their prior price target of $91.00. A number of other equities research […]
Eagle Asset Management Inc. boosted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 256,842 shares of the biopharmaceutical company’s stock after buying an additional 511 shares during the quarter. Eagle […]